Predictive value of prognostic nutritional index (PNI) in recurrent or unresectable hepatocellular carcinoma received anti-PD1 therapy.

Kang, Xindan; Wang, Jing; Kang, Xue; Bai, Li

Kang, Xindan; Wang, Jing; Kang, Xue; Bai, Li.

Afiliação

Kang X; Department of Respiratory and Critical Care Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army General Hospital, Beijing, 100089, China.
Wang J; Department of Oncology, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, 100036, China.
Kang X; Department of General Medicine, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, 100036, China.
Bai L; Department of Oncology, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, 100036, China.

BMC Cancer ; 23(1): 787, 2023 Aug 23.

Article em En | MEDLINE | ID: mdl-37612634

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/tratamento farmacológico; Prognóstico; Estudos Retrospectivos; Avaliação Nutricional; Neoplasias Hepáticas/tratamento farmacológico; Hospitais Gerais

Palavras-chave

Anti-PD1; Immune checkpoint inhibitors; PNI; Unresectable hepatocellular carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Cancer Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google